Healthy volunteers needed to test new combo pill

NCT ID NCT07622433

Not yet recruiting Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 15, 2026 · Last updated Jun 15, 2026

Summary

This early-stage study will test whether a single tablet containing two drugs (laroprovstat and ezetimibe) works the same in the body as taking each drug separately. It will also check if eating affects how the drugs are absorbed. The study involves 18 healthy adults aged 18 to 55 and is not intended to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    Brooklyn, Maryland, 21225, United States

Conditions

Explore the condition pages connected to this study.